ADA anticorps (C-Term)
Aperçu rapide pour ADA anticorps (C-Term) (ABIN950276)
Antigène
Voir toutes ADA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 294-322, C-Term
-
Specificité
- This antibody reacts to Adenosine deaminase.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human.
-
Purification
- Affinity chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide between 294-322 amino acids from the C-terminal region of human ADA
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ADA (Adenosine Deaminase (ADA))
-
Sujet
- This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine. Various mutations have been described for this gene and have been linked to human diseases. Deficiency in this enzyme causes a form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins, whereas elevated levels of this enzyme have been associated with congenital hemolytic anemia.Synonyms: Adenosine aminohydrolase
-
ID gène
- 100
-
NCBI Accession
- NP_000013
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Ribonucleoside Biosynthetic Process
Antigène
-